Publication | Closed Access

Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection

VaccinationTumor ProtectionHuman Papillomavirus VaccinesVaccine TargetImmunologyHepatitisTherapeutic VaccineVaccine DesignPolyvalent VaccineImmunotherapyMedicineHuman Papillomavirus OncoproteinsCancer-associated Virus